Page last updated: 2024-08-26

fulvestrant and seocalcitol

fulvestrant has been researched along with seocalcitol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Binderup, L; Colston, KW; James, SY; Mackay, AG	1
Christensen, GL; Christensen, IJ; Fog, CK; Jepsen, JS; Lykkesfeldt, AE	1

Other Studies

2 other study(ies) available for fulvestrant and seocalcitol

Article	Year
Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells. The Journal of endocrinology, 1994, Volume: 141, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Time Factors; Tumor Cells, Cultured	1994
Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment. Breast cancer research and treatment, 2004, Volume: 85, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; Genes, bcl-2; Humans; Predictive Value of Tests; Receptors, Calcitriol; Receptors, Estrogen; Tamoxifen; Vitamin D	2004

Article

Year

Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.

The Journal of endocrinology, 1994, Volume: 141, Issue:3

Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Time Factors; Tumor Cells, Cultured

1994

Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.

Breast cancer research and treatment, 2004, Volume: 85, Issue:1

Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; Genes, bcl-2; Humans; Predictive Value of Tests; Receptors, Calcitriol; Receptors, Estrogen; Tamoxifen; Vitamin D

2004